Page last updated: 2024-11-03

propafenone and Pulmonary Edema

propafenone has been researched along with Pulmonary Edema in 2 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Pulmonary Edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nawrocka, I1
KaczyƄska, A1
Abramczyk, P1
Kolettis, TM1
Naka, KK1
Katsouras, C1
Michalis, LK1
Bourantas, K1

Other Studies

2 other studies available for propafenone and Pulmonary Edema

ArticleYear
Electric cardioversion of atrial fibrillation resulting in pulmonary oedema in patient with apical hypertrophic cardiomyopathy.
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2015, Volume: 38, Issue:227

    Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Diuretics; Electric Count

2015
Transient intraventricular conduction delay associated with concurrent intake of propafenone and antineoplastic agents.
    Cardiovascular drugs and therapy, 2003, Volume: 17, Issue:4

    Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Antineoplastic Agents; Drug Interact

2003